Recent CRM news and press releases.
Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments.
Medical Research Council scientists at the University of Edinburgh have been able to generate cells in the laboratory that reach the gold standard required by the pharmaceutical industry to test drug safety.
Roslin Cells Ltd, the Scottish National Blood Transfusion Service (SNBTS) and the University of Edinburgh announced today that the GMP Cellular Therapy Manufacturing Facility within the Scottish Centre for Regenerative Medicine (SCRM) has recently been licensed by the Medicines and Healthcare products Regulatory
Scientists have taken a vital step forward in understanding how cells from skin tissue can be reprogrammed to become stem cells.
During the reprogramming process adult cells, such as fibroblasts (left), are transformed into induced pluripotent stem cells (right).
The MRC Centre for Regenerative Medicine (CRM) has embarked on an ambitious public engagement project to travel to remote areas of Scotland with the aim to give local communities the opportunity to interact face-to-face with scientists working in the regenerative medicine field.
Scientists at the University of Edinburgh’s MRC Centre for Regenerative Medicine (CRM) have made a fundamental discovery about how the properties of embryonic stem cells are controlled. The study, which focuses on the process by which these cells renew and increase in number, could help research to find new treatments.